Abstract
In this chapter we compare the development, characteristics, validity and reliability of two widely used quality of life (QOL) assessment tools in lung cancer: the EORTC QLQLC13 and the FACT-L. The authors found that both questionnaires were developed from input of patients and health care professionals. The QLQ-LC13 is a 13-item instrument that assesses coughing, hemoptysis, dyspnea and pain and the side effects of treatment. Two international field studies have concluded that the QLQ-LC13 is clinically valid and useful. Conversely, the FACT-L assesses general QOL and seven lung cancer-specific items, such as shortness of breath, weight loss, cough, and appetite. In a study of 116 lung cancer patients, the FACT-L was found to have a good internal consistency, reliability, and sensitivity to changes in performance status. Ultimately, both the EORTC QLQ-LC13 and the FACT-L have been sufficiently validated; as such, decision-making should depend on the needs of the investigation.
Original language | English (US) |
---|---|
Title of host publication | Cancer |
Subtitle of host publication | Treatment, Decision Making and Quality of Life |
Publisher | Nova Science Publishers, Inc. |
Pages | 79-92 |
Number of pages | 14 |
ISBN (Electronic) | 9781634838825 |
ISBN (Print) | 9781634838634 |
State | Published - Jan 1 2016 |
ASJC Scopus subject areas
- General Medicine